Results 12,821-12,840 of 14,090 for speaker:Marc MacSharry
- Written Answers — Department of Health: Medicinal Products (29 Sep 2020)
Marc MacSharry: 860. To ask the Minister for Health the status of the reimbursement of teduglutide for children with short bowel syndrome; and if he will make a statement on the matter. [26691/20]
- Written Answers — Department of Health: Vaccination Programme (29 Sep 2020)
Marc MacSharry: 861. To ask the Minister for Health if the flu vaccine for children aged two to twelve will be made available for free for the 2021 winter period and beyond; and if he will make a statement on the matter. [26692/20]
- Written Answers — Department of Health: Healthcare Infrastructure Provision (29 Sep 2020)
Marc MacSharry: 862. To ask the Minister for Health when the construction of a new acute mental health unit at Sligo University Hospital will be completed; the estimated cost of the project; and if he will make a statement on the matter. [26693/20]
- Forestry (Miscellaneous Provisions) Bill 2020 [Seanad]: Second Stage (Resumed) (30 Sep 2020)
Marc MacSharry: Deputy Farrell and I are sharing three and a half minutes each, unless there is any time residue left over from the previous speaker. I imagine we would happily use that too. I thank the Minister of State for the opportunity to address this Bill. I welcome the legislation on the whole. We badly need to address the long backlogs from concerned communities, in terms of appeals that are...
- Public Accounts Committee: Business of Committee (Resumed) (30 Sep 2020)
Marc MacSharry: We could hold it over for him in case he asked specifically. That was what we would have done in the past.
- Public Accounts Committee: Business of Committee (Resumed) (30 Sep 2020)
Marc MacSharry: If a member had to pop out or be at another committee then we would keep it for them.
- Public Accounts Committee: Business of Committee (Resumed) (30 Sep 2020)
Marc MacSharry: I agree with that. Given the new format with the two hour meetings, in situations where we might be bringing in the OPW, the Irish Prison Service, An Garda and others, it is going to take a number of meetings. Two hours is not going to cover it and I would rather we did not have only a cursory glance over what will be very important issues, because of limitations on time. That will also...
- Public Accounts Committee: Business of Committee (Resumed) (30 Sep 2020)
Marc MacSharry: I note that the individual who is corresponding has a lot of experience as a former employee. A lot of documentation was received by the previous committee and this committee. We could usefully go through that and maybe pick out up to half a dozen key items that we want to pursue with him.
- Public Accounts Committee: Business of Committee (Resumed) (30 Sep 2020)
Marc MacSharry: We are in public session.
- Public Accounts Committee: Business of Committee (Resumed) (30 Sep 2020)
Marc MacSharry: I understand with regard to conflict of interest but it was a non-executive position heading up an organisation and it is in the public interest. All of us have been in contact with the Irish Road Haulage Association in various capacities over the years to raise issues. I know exactly what Deputy Hourigan is saying, and it is appropriate that it is said, but there are 12 others of us of...
- Public Accounts Committee: Business of Committee (Resumed) (30 Sep 2020)
Marc MacSharry: We have mandates.
- Public Accounts Committee: Business of Committee (Resumed) (30 Sep 2020)
Marc MacSharry: It comes down to the invitation thing again. There are other issues with the RSA, independent of Deputy Verona Murphy's. I mentioned one last week. When we get to the work programme, we will call them in. Let the Department's witnesses bring representatives from the RSA with them if they want. We are entitled to call the RSA in its own right, as far as I am aware. The Department will do...
- Public Accounts Committee: Business of Committee (Resumed) (30 Sep 2020)
Marc MacSharry: Can we hold it over for him?
- Public Accounts Committee: Business of Committee (Resumed) (30 Sep 2020)
Marc MacSharry: What was the issue?
- Public Accounts Committee: Business of Committee (Resumed) (30 Sep 2020)
Marc MacSharry: Did the issue relate to something they had said in evidence?
- Public Accounts Committee: Business of Committee (Resumed) (30 Sep 2020)
Marc MacSharry: While I know that we will deal with it next week, I refer to an issue that features on the front page of the Irish Examinertoday. It would be remiss of the committee not to acknowledge the gravity of the situation with regard to utterances made in the Committee of Public Accounts being ruled by a Workplace Relations Commission, WRC, adjudicator to have been the reason for an agency nurse,...
- Public Accounts Committee: Business of Committee (Resumed) (30 Sep 2020)
Marc MacSharry: I have circulated the judgment handed down in the case. I request that the committee considers the two articles that have appeared in the media today and they should perhaps also be circulated to members.
- Public Accounts Committee: Special Report of the Comptroller and Auditor General on the Nursing Homes Support Scheme: Discussion (1 Oct 2020)
Marc MacSharry: I welcome everyone and offer good wishes to Dr. O'Reardon in his new role. I thank Mr. Reid and everyone from the HSE for giving their time at this most difficult time for themselves. As someone who is mercilessly critical at times, I want to take the opportunity to thank the HSE and the Department of Health and all associated with them for their mountain-moving heroics over recent months...
- Public Accounts Committee: Special Report of the Comptroller and Auditor General on the Nursing Homes Support Scheme: Discussion (1 Oct 2020)
Marc MacSharry: I am conscious that the witnesses have not come here to discuss that matter so it is why I asked for a written note. I have a minute of my time left.
- Public Accounts Committee: Special Report of the Comptroller and Auditor General on the Nursing Homes Support Scheme: Discussion (1 Oct 2020)
Marc MacSharry: Sure. I totally understand that speed trumps accuracy now and there is a need for this. However, based on the predicted unfortunate longevity of this disease, we could usefully carry out that exercise. We should do it. I will leave it at that. There is a lack of data provided to help the value for money report. Who is not providing that data?